Related Experiment Videos

First-pass renal perfusion imaging using MS-325, an albumin-targeted MRI contrast agent

P V Prasad1, J Cannillo, D R Chavez

  • 1Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA.

Investigative Radiology
|September 15, 1999
PubMed
Abstract

Insights

New MR imaging techniques using MS-325 show promise for evaluating renal artery stenosis. This method provides quantitative perfusion estimates, improving the comprehensive assessment of kidney artery conditions.

Area of Science:

  • Radiology
  • Medical Imaging
  • Vascular Imaging

Background:

  • Magnetic resonance (MR) angiography is valuable for diagnosing renal artery disorders.
  • Current MR angiography has limitations in characterizing renal artery stenosis.
  • Renal perfusion imaging may offer supplemental data for comprehensive evaluation.

Purpose of the Study:

  • To evaluate MS-325 for first-pass perfusion imaging and contrast-enhanced MR angiography.
  • To assess the characterization of renal artery stenosis in an animal model using MS-325.

Main Methods:

  • MS-325, a blood pool agent with enhanced relaxivity and blood residence time, was administered.
  • First-pass perfusion imaging and contrast-enhanced MR angiography were performed.
  • Quantitative perfusion estimates were obtained in the renal cortex.

Main Results:

  • Renal cortical perfusion estimates (258 +/- 19.8 mL/min/100 g) were comparable to microsphere measurements (198 +/- 12.2 mL/min/100 g).
  • Perfusion demonstrated minimal changes despite up to 75% diameter reduction in renal arteries.
  • MS-325 facilitated both perfusion imaging and MR angiography.

Conclusions:

  • MS-325 enables quantitative perfusion estimation in the kidneys.
  • Combining MS-325-based perfusion imaging with MR angiography offers a comprehensive approach to evaluating renal artery stenosis.
  • This integrated MR imaging technique enhances the diagnostic utility for renal vascular disorders.

Related Concept Videos